1 / 1

Hutcheson, J. D. et al. (2014) Potential drug targets for calcific aortic valve disease

Figure 3 Cardiovascular inflammation and calcification. Figure 3a–c: reprinted from Aikawa, E. et al. Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation 119 (13), 1785–1794 (2009).

ezekiel-hewitt
Download Presentation

Hutcheson, J. D. et al. (2014) Potential drug targets for calcific aortic valve disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Figure 3 Cardiovascular inflammation and calcification Figure 3a–c: reprinted from Aikawa, E. et al. Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation 119 (13), 1785–1794 (2009) Figure 3d: reprinted from Aikawa, E. et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 116 (24), 2841–2850 (2007) Hutcheson, J. D. et al. (2014) Potential drug targets for calcific aortic valve disease Nat. Rev. Cardiol. doi:10.1038/nrcardio.2014.1

More Related